Haemodynamic Effect of Intravenous Paracetamol during and after Cardiac Surgery
Phase 4
Completed
- Conditions
- Cardiopulmonary bypassCardiac surgeryAnaesthesiology - AnaestheticsSurgery - Surgical techniquesCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12615001099516
- Lead Sponsor
- Austin Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Adult surgery patients (age >18 years)
2. Cardiac surgery requiring cardiopulmonary bypass
Exclusion Criteria
Paracetamol use 24 hours prior to surgery (in paracetamol only or in combination therapy)
Pregnancy
Chronic renal impairment (creatinine >250 umol/L)
Chronic liver disease (ALT >200IU/L)
Morbid obesity (BMI >35kg/m2)
Known allergic reaction to IV paracetamol
Consumption of caffeine (e.g. coffee or energy drinks), consumed within 10 hours of surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is a composite outcome using pressure based haemodynamic variables, namely systolic blood pressure, diastolic blood pressure, mean arterial blood pressure. These will be recorded from a arterial line inserted as part of standard care that measure continuous systolic blood pressure, diastolic blood pressure, and mean arterial blood pressure.[The primary outcome will be measures at the following peri-operative timepoints using the measurements from the arterial line. <br><br>1. Baseline (BL) just after pulmonary artery catheter insertion<br>2. 5 minutes (T5)<br>3. 10 minutes (T10)<br>4. 15 minutes (T15)<br>5. 30 minutes (T30)<br>6. Pre-cardiopulmonary bypass<br>7. Rewarming<br>8. ICU arrival (ICU 1)<br>9. ICU 6 hours (ICU 6)<br>10. ICU 12 hours (ICU 12)]
- Secondary Outcome Measures
Name Time Method